Infection Control Surveillance Solutions Market Size & Share 2022 to 2030

Market Size by Component (Software {On-Premise, Web-Based}, Services), by End User (Hospitals, Clinics, Specialty Centers, Ambulatory Surgical Centers) & Forecast.
Report ID: GMI5312
   |
Published Date: August 2022
 | 
Report Format: PDF

Download Free PDF

Infection Control Surveillance Solutions Market Size

Infection Control Surveillance Solutions Market size surpassed USD 580 million in 2021 and is projected to expand at a CAGR of over 13% between 2022 and 2030. The prevalence of nosocomial infections will spur the global industry growth.
 

Infection Control Surveillance Solutions Market

The increasing prevalence of nosocomial infections is among the primary factors supporting the industry expansion during the forecast period. Nosocomial infections or Healthcare-associated infections (HAI) are acquired due to prolonged stay or while undergoing treatment across hospital settings. They usually occur within 48 hours or 30 days post-discharge and may include urinary tract infections, surgical site wound infections, respiratory pneumonia, bacteremia, and gastrointestinal and skin infections, among others.
 

 

According to the Center for Disease Control and Prevention estimations under the National Healthcare Safety Network (NHSN), urinary tract infections (UTIs) are the most common and widespread hospital-associated infections. In addition, the rapid growth of the aging population and their susceptibility to such infections are likely to create new growth prospects for the infection control surveillance solutions industry in the forthcoming years.
 

Infection Control Surveillance Solutions Market Analysis

Infection Control Surveillance Solutions Market, by Component,

With respect to the component, the infection control surveillance solutions market is bifurcated into software and services. The software segment held more than USD 370 million in revenue in 2021 and is anticipated to follow a positive growth trajectory between 2022 and 2030. The segmental expansion can be credited to the emergence of several healthcare-associated infections and subsequent growth in demand for infection control software. According to the Office of Disease Prevention and Health Promotion, 1 out of every 25 hospitalized patients at any given time in the United States are affected by a healthcare-associated infection. This software help analyzes and shares real-time data and provides feedback that helps medical teams and staff mitigate and control infections more effectively, which will boost its adoption in the forthcoming years.
 

Infection Control Surveillance Solutions Market, by End-use,

Based on end-use, the infection control surveillance solutions market is categorized into hospitals, clinics, ambulatory surgical centers, and specialty centers. The hospital segment accounted for more than 67% of the industry share in 2021 and is poised to register significant progress during the assessment period. The increasing burden of infectious and chronic health disorders has resulted in a growing number of people requiring frequent hospitalizations, leading to a considerable rise in hospital-acquired infections and associated healthcare expenditure. This has boosted the demand for better healthcare infrastructure resulting in the construction of new hospitals and healthcare facilities, strengthening the industry outlook.
 

Infection Control Surveillance Solutions Market, by Region

The North America infection control surveillance solutions market constituted over 44% of the revenue share in 2021 and is likely to experience further expansion in the foreseeable future. The region has registered a noticeable rise in disposable incomes and a significant improvement in economic growth. In addition, the rising healthcare concerns have significantly pushed the healthcare expenditure across the region. North America houses several industry participants that have been focusing on introducing better and advanced products in the market, creating a pool of opportunities for the regional industry.
 

Infection Control Surveillance Solutions Market Share

Some of the prominent companies constituting the infection control surveillance solutions market competitive landscape include players such as

  • Baxter International Inc.
  • Premier, Inc.
  • Cerner Corporation
  • Becton, Dickinson and Company (BD)
  • GOJO Industries, Inc.
  • Sunquest
  • IBM Corporation
  • OASIS Medical
  • Ecolab Inc.
  • Harris Healthcare
  • CenTrak, Inc.
  • Roper Technologies

These firms have been implementing technological breakthroughs and new product development as their key growth strategy.
 

These advanced innovations help them improve their product offerings while offering them a competitive edge over their rival organizations. For instance, in June 2022, Premier announced the expansion of its PINC AI technology platform for clinical surveillance across long-term care facilities. The platform efficiently documents and records data about several infections and offer features such as automatic alerts, poised to broaden the company’s existing customer base.
 

Impact of COVID-19 Pandemic

The outbreak of the COVID-19 pandemic emerged as a boon for the infection control surveillance solutions industry. The exponential rise in COVID-positive patients and the rapidly growing rate of viral transmission resulted in the overcrowding of healthcare facilities. The increasing number of patients requiring hospitalization and critical care caused a dearth of medical staff and hospital beds, pushing the demand for appropriate infection control surveillance systems. In addition, the increasing severity of cruising and the surging morbidities and mortalities led to the growing awareness about safety, health, and hygiene, spurring the demand for infection control measures, thereby facilitating infection control surveillance systems market growth.
 

The infection control surveillance solutions market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2030 for the following segments:

By Component

  • Software 
    • On-premise
    • Web-based
  • Services

By End-user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Specialty Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Others
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Others

 

Authors: Monali Tayade, Jignesh Rawal
Infection Control Surveillance Solutions Market Scope
  • Infection Control Surveillance Solutions Market Size
  • Infection Control Surveillance Solutions Market Trends
  • Infection Control Surveillance Solutions Market Analysis
  • Infection Control Surveillance Solutions Market Share

Report Content

Chapter 1   Methodology & Scope

1.1    Methodology

1.2    Base estimates and working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    MEA

1.3    Forecast parameters

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1   Paid sources

1.5.1.2   Public sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Infection control surveillance solutions industry 360° synopsis, 2017 - 2030

2.1.1    Business trends

2.1.2    Component trends

2.1.3    End-user trends

2.1.4    Regional trends

Chapter 3   Infection Control Surveillance Solutions Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2030

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Surge in the number of nosocomial infections

3.3.1.2   Rising technological advancements in the healthcare IT infrastructure

3.3.1.3   Growing prevalence of infectious and chronic diseases

3.3.2    Industry pitfalls & challenges

3.3.2.1   Unwillingness among healthcare professionals to adopt innovative healthcare IT solutions

3.3.2.2   Improper data management and lack of knowledge regarding IT among healthcare professionals

3.4    Growth potential analysis

3.4.1    By component

3.4.2    By end-user

3.5    COVID- 19 impact analysis

3.6    Porter's analysis

3.6.1    Bargaining power of suppliers

3.6.2    Bargaining power of buyers

3.6.3    Threat of new entrants

3.6.4    Threat of substitutes

3.7    Competitive landscape, 2021

3.7.1    Company matrix analysis, 2021

3.8    PESTEL analysis

Chapter 4   Infection Control Surveillance Solutions Market, By Component

4.1    Key segment trends

4.2    Software

4.2.1    Market size, by region, 2017 - 2030 (USD Million)

4.2.2    On-premise

4.2.2.1   Market size, by region, 2017 - 2030 (USD Million)

4.2.3    Web-based

4.2.3.1   Market size, by region, 2017 - 2030 (USD Million)

4.3    Services

4.3.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 5   Infection Control Surveillance Solutions Market, By End-user

5.1    Key segment trends

5.2    Hospitals

5.2.1    Market size, by region, 2017 - 2030 (USD Million)

5.3    Clinics

5.3.1    Market size, by region, 2017 - 2030 (USD Million)

5.4    Ambulatory surgical centers

5.4.1    Market size, by region, 2017 - 2030 (USD Million)

5.5    Specialty centers

5.5.1    Market size, by region, 2017 - 2030 (USD Million)

5.6    Others

5.6.1    Market size, by region, 2017 - 2030 (USD Million)

Chapter 6   Infection Control Surveillance Solutions Market, By Region

6.1    Key regional trends

6.2    North America

6.2.1    Market size, by country, 2017 - 2030 (USD Million)

6.2.2    Market size, by component, 2017 - 2030 (USD Million)

6.2.2.1   Market size, by software, 2017 - 2030 (USD Million)

6.2.3    Market size, by end-user, 2017 - 2030 (USD Million)

6.2.4    U.S.

6.2.4.1   Market size, by component, 2017 - 2030 (USD Million)

6.2.4.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.2.4.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.2.5    Canada

6.2.5.1   Market size, by component, 2017 - 2030 (USD Million)

6.2.5.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.2.5.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.3    Europe

6.3.1    Market size, by country, 2017 - 2030 (USD Million)

6.3.2    Market size, by component, 2017 - 2030 (USD Million)

6.3.2.1   Market size, by software, 2017 - 2030 (USD Million)

6.3.3    Market size, by end-user, 2017 - 2030 (USD Million)

6.3.4    Germany

6.3.4.1   Market size, by component, 2017 - 2030 (USD Million)

6.3.4.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.3.4.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.3.5    UK

6.3.5.1   Market size, by component, 2017 - 2030 (USD Million)

6.3.5.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.3.5.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.3.6    France

6.3.6.1   Market size, by component, 2017 - 2030 (USD Million)

6.3.6.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.3.6.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.3.7    Spain

6.3.7.1   Market size, by component, 2017 - 2030 (USD Million)

6.3.7.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.3.7.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.3.8    Italy

6.3.8.1   Market size, by component, 2017 - 2030 (USD Million)

6.3.8.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.3.8.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.4    Asia Pacific

6.4.1    Market size, by country, 2017 - 2030 (USD Million)

6.4.2    Market size, by component, 2017 - 2030 (USD Million)

6.4.2.1   Market size, by software, 2017 - 2030 (USD Million)

6.4.3    Market size, by end-user, 2017 - 2030 (USD Million)

6.4.4    China

6.4.4.1   Market size, by component, 2017 - 2030 (USD Million)

6.4.4.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.4.4.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.4.5    Japan

6.4.5.1   Market size, by component, 2017 - 2030 (USD Million)

6.4.5.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.4.5.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.4.6    India

6.4.6.1   Market size, by component, 2017 - 2030 (USD Million)

6.4.6.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.4.6.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.4.7    South Korea

6.4.7.1   Market size, by component, 2017 - 2030 (USD Million)

6.4.7.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.4.7.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.4.8    Australia

6.4.8.1   Market size, by component, 2017 - 2030 (USD Million)

6.4.8.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.4.8.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.5    Latin America

6.5.1    Market size, by country, 2017 - 2030 (USD Million)

6.5.2    Market size, by component, 2017 - 2030 (USD Million)

6.5.2.1   Market size, by software, 2017 - 2030 (USD Million)

6.5.3    Market size, by end-user, 2017 - 2030 (USD Million)

6.5.4    Brazil

6.5.4.1   Market size, by component, 2017 - 2030 (USD Million)

6.5.4.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.5.4.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.5.5    Mexico

6.5.5.1   Market size, by component, 2017 - 2030 (USD Million)

6.5.5.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.5.5.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.5.6    Argentina

6.5.6.1   Market size, by component, 2017 - 2030 (USD Million)

6.5.6.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.5.6.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.6    Middle East & Africa

6.6.1    Market size, by country, 2017 - 2030 (USD Million)

6.6.2    Market size, by component, 2017 - 2030 (USD Million)

6.6.2.1   Market size, by software, 2017 - 2030 (USD Million)

6.6.3    Market size, by end-user, 2017 - 2030 (USD Million)

6.6.4    Saudi Arabia

6.6.4.1   Market size, by component, 2017 - 2030 (USD Million)

6.6.4.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.6.4.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.6.5    South Africa

6.6.5.1   Market size, by component, 2017 - 2030 (USD Million)

6.6.5.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.6.5.2   Market size, by end-user, 2017 - 2030 (USD Million)

6.6.6    UAE

6.6.6.1   Market size, by component, 2017 - 2030 (USD Million)

6.6.6.1.1    Market size, by software, 2017 - 2030 (USD Million)

6.6.6.2   Market size, by end-user, 2017 - 2030 (USD Million)

Chapter 7   Company Profiles

7.1    Competitive dashboard, 2021

7.2    Oracle (Cerner Corporation)

7.2.1    Business overview

7.2.2    Financial data

7.2.3    Product landscape

7.2.4    Strategic outlook

7.2.5    SWOT analysis

7.3    Baxter International Inc.

7.3.1    Business overview

7.3.2    Financial data

7.3.3    Product landscape

7.3.4    Strategic outlook

7.3.5    SWOT analysis

7.4    Becton, Dickinson and Company (BD)

7.4.1    Business overview

7.4.2    Financial data

7.4.3    Product landscape

7.4.4    Strategic outlook

7.4.5    SWOT analysis

7.5    Premier (TheraDoc)

7.5.1    Business overview

7.5.2    Financial data

7.5.3    Product landscape

7.5.4    Strategic outlook

7.5.5    SWOT analysis

7.6    Harris Healthcare.

7.6.1    Business overview

7.6.2    Financial data

7.6.3    Product landscape

7.6.4    Strategic outlook

7.6.5    SWOT analysis

7.7    Epic Systems Corporation

7.7.1    Business overview

7.7.2    Financial data

7.7.3    Product landscape

7.7.4    Strategic outlook

7.7.5    SWOT analysis

7.8    Asolva Inc

7.8.1    Business overview

7.8.2    Financial data

7.8.3    Product landscape

7.8.4    Strategic outlook

7.8.5    SWOT analysis

7.9    International Business Machines Corporation (IBM)

7.9.1    Business overview

7.9.2    Financial data

7.9.3    Product landscape

7.9.4    Strategic outlook

7.9.5    SWOT analysis

7.10    Ecolab

7.10.1    Business overview

7.10.2    Financial data

7.10.3    Product landscape

7.10.4    Strategic outlook

7.10.5    SWOT analysis

7.11    Wolters Kluwer N.V

7.11.1    Business overview

7.11.2    Financial data

7.11.3    Product landscape

7.11.4    Strategic outlook

7.11.5    SWOT analysis

7.12    Halma plc. (Centrak)

7.12.1    Business overview

7.12.2    Financial data

7.12.3    Product landscape

7.12.4    Strategic outlook

7.12.5    SWOT analysis

7.13    Roper Technologies

7.13.1    Business overview

7.13.2    Financial data

7.13.3    Product landscape

7.13.4    Strategic outlook

7.13.5    SWOT analysis

7.14    PeraHealth

7.14.1    Business overview

7.14.2    Financial data

7.14.3    Product landscape

7.14.4    Strategic outlook

7.14.5    SWOT analysis

7.15    VigiLanz

7.15.1    Business overview

7.15.2    Financial data

7.15.3    Product landscape

7.15.4    Strategic outlook

7.15.5    SWOT analysis

7.16    Vecna Technologies, Inc.

7.16.1    Business overview

7.16.2    Financial data

7.16.3    Product landscape

7.16.4    Strategic outlook

7.16.5    SWOT analysis

7.17    BioVigil Healthcare Systems, Inc.

7.17.1    Business overview

7.17.2    Financial data

7.17.3    Product landscape

7.17.4    Strategic outlook

7.17.5    SWOT analysis

Don't see your key competitors?

The companies listed in this report are a curated selection - not the full competitive universe.

Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.

Your competitive landscape may also include

Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use

Free customization - up to 20% of report value

Need specific data? Request customization and get the insights tailored to your exact requirements.

Authors: Monali Tayade, Jignesh Rawal

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Explore Our Licensing Options:

Starting at: $2,450

Immediate Delivery Available

Premium Report Details

Base Year: 2021

Companies Profiled: 12

Tables & Figures: 182

Countries covered: 18

Pages: 240

Download Free PDF

img

Infection Control Surveillance Solutions Market

Get a free sample of this report
country Flag
+1
img
Get a free sample of this report Infection Control Surveillance Solutions Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Your personal details will remain secure and confidential.

Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!